The clinical safety of omeprazole

scientific article published on 01 January 1989

The clinical safety of omeprazole is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/00365528909091255
P698PubMed publication ID2690327

P2093author name stringL Sölvell
P921main subjectomeprazoleQ422210
P304page(s)106-10; discussion 111-3
P577publication date1989-01-01
P1433published inScandinavian Journal of Gastroenterology. SupplementQ15753697
P1476titleThe clinical safety of omeprazole
P478volume166

Reverse relations

cites work (P2860)
Q42536099Anaphylaxis to omeprazole
Q42762656Angio-edema and urticaria associated with omeprazole
Q33560142Formulary management of antiulcer drugs: clinical considerations
Q43221363Oesophageal candidiasis after omeprazole therapy
Q67734053Omeprazole in Post-Gastrocystoplasty Metabolic Alkalosis and Aciduria
Q42038731Omeprazole induces altered bile acid metabolism
Q34594257Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders
Q28323057Painful gynaecomastia during omeprazole therapy
Q39475567Pharmacological Management of Gastro-Oesophageal Reflux Disease
Q40844869Prescribing policy for antiulcer treatment in the elderly
Q35250682Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease
Q40595584Safety of acid-suppressing drugs
Q33542545Safety profile of Lansoprazole: the US clinical trial experience
Q41190759Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists

Search more.